Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection
AMSTERDAM—With new therapies coming into the marketplace, researchers are working to tease out the risk of infection for rheumatoid arthritis (RA) patients. Existing data suggest the risk of infections—even fatal ones—is real. But over time, improvements have taken hold, particularly for tuberculosis, according to an infectious disease expert at EULAR: the Annual European Congress of... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Thomas R. Collins Tags: Biologics & Biosimilars Conditions Drug Updates Rheumatoid Arthritis Infection Tuberculosis Source Type: research
More News: Arthritis | Infectious Diseases | Politics | Rheumatoid Arthritis | Rheumatology | Tuberculosis